Your session is about to expire
← Back to Search
Hearing Aid Enhancements for Hearing Loss
N/A
Recruiting
Led By Virginia A Best, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group
Summary
This trial is investigating whether three different approaches can improve hearing for people who use hearing aids. The approaches being tested are increased high-frequency audibility, speech envelope enhancement, and appropriate sound image externalization.
Who is the study for?
This trial is for adults with hearing loss. Young adults (18-35) must have normal hearing levels, while older participants (up to 80) should have sensorineural hearing loss. All must understand English, provide consent, and have normal or corrected vision.
What is being tested?
The study tests if spatial perception and speech clarity in noisy environments can be improved for hearing aid users through increased high-frequency sounds, speech envelope enhancement, or better sound image externalization.
What are the potential side effects?
There are no direct side effects mentioned for this trial as it involves non-invasive testing of different hearing aid settings rather than medication or surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Externalization rating at baseline
Externalization rating post-intervention
Interaural time difference discrimination at baseline
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental conditionExperimental Treatment1 Intervention
Participants will be presented with sound stimuli under a number of experimental conditions that simulate different hearing-aid conditions.
Find a Location
Who is running the clinical trial?
Boston University Charles River CampusLead Sponsor
119 Previous Clinical Trials
13,085 Total Patients Enrolled
1 Trials studying Hearing Loss
40 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
352 Previous Clinical Trials
180,969 Total Patients Enrolled
59 Trials studying Hearing Loss
20,990 Patients Enrolled for Hearing Loss
Virginia A Best, PhDPrincipal InvestigatorBoston University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18-35, with normal hearing and vision (with or without correction), and can understand the study.I am between 18-80 years old with sensorineural hearing loss and can see normally or with correction.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger